Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140075
Status:
COMPLETED
Last Update Posted:
2011-05-26
First Post:
2005-08-29
Brief Title:
Adjuvant EpirubicinCytoxan Followed By A Taxane VS EpirubicinTaxane As Treatment For Node-Positive Breast Cancer
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adenocarcinoma |
Keywords: